Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Buyuan Zhixiao Formula is a traditional Chinese medicine (TCM) herbal formulation investigated for its potential to treat elderly patients with diabetes and multiple metabolic disorders. Clinical studies suggest it may help improve blood sugar control, lower blood pressure, reduce lipid levels, support cognitive function, and prevent arteriosclerosis. The formula is being evaluated in clinical trials for its efficacy in managing metabolic syndrome components such as hyperglycemia, hypertension, dyslipidemia, and obesity[1][2][7]. The precise mechanism of action is not fully elucidated but likely involves multi-target modulation typical of TCM herbal combinations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Buyuan Zhixiao Formula.